Milestone Pharmaceuticals Inc
MIST
Get informed when a big investor buys or sells
+ FollowMarket Cap$104.78M
Close$
$0.17
84.4% downside
Current Fair Value
84.4% downsideOvervalued by 84.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $104.78 Million |
|---|---|
| Enterprise Value | $-3,840,557.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.75 |
| Beta | 0.97 |
| Outstanding Shares | 130,286,033 |
Return
| Return on Equity | -485.27% |
|---|---|
| Return on Assets | -48.68% |
| Return on Invested Capital | -42.06% |
Valuation & Multiples
| P/E Ratio | -1.79 |
|---|---|
| PEG | -1.49 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -1.72 |
| Enterprise Value to EBIT | 0.06 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -15.91 |
| Debt to Equity | 3.35 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$816,667
Average shareholder expectationNext Earnings Call
Expected Date
November 17, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$1.20 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 7.3085▲ 243.70% |
|---|---|
| Total Calls | 36,300▼ 79.19% |
| Total Puts | 265,300▼ 68.77% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 47.12%▲ 15.54% |
|---|---|
| Total Invested | $47.22M▼ 11.85% |
| Investors Holding | 91▲ 5.00% |
ESG Score
No data